Chimeric Antigen Receptor T‑cell Therapy for B-Cell Non-Hodgkin Lymphoma: Opportunities and Challenges. Вопр. онкол. 2021, 67 (3), 350-360. https://doi.org/10.37469/0507-3758-2021-67-3-350-360.